DeepIntent Appoints Amit Chaturvedi as Chief Operating Officer


Seasoned Executive Brings Expertise to High-Growth Companies as Pharma Programmatic Ad Spend Spikes

NEW YORK, August 8, 2022 /PRNewswire/ — DeepIntentthe leader in healthcare advertising technology, designed to improve patient health and business outcomes, today announced the appointment of Amit Chaturvedi as the first managing director.


Chaturvedi joins DeepIntent with over two decades of experience operating ad tech startups and global media companies. In his last role as Executive Vice President of Revenue and Product Operations at WarnerMedia, Chaturvedi led the company’s linear and digital revenue operations functions and was responsible for unifying the offerings and strategy of cross-platform revenue with a particular focus on advanced digital solutions including CTV and audience solutions. During his tenure, revenue grew more than 10-fold, with total revenue under management exceeding $5 billion annually. Chaturvedi also served as COO of Taykey, a Sequoia and Softbank-backed startup that was acquired by global connected television (CTV) leader Innovid in 2017, with prior experiences including roles as leadership at aQuantive (acquired by Microsoft), IAC/InterActiveCorp and QualityHealth (acquired by Sharecare).

As DeepIntent’s first Chief Operating Officer, Chaturvedi will be responsible for all of DeepIntent’s business operations and will report directly to the company’s Founder and CEO, Chris Paquette. Chaturvedi’s primary focus will be to integrate and further develop DeepIntent’s sales, campaign management, customer success and business development teams as the company executes its plan to further define itself as the leading platform. form of digital health advertising.

“Amit’s hands-on operational experience and proven track record of scaling similar-sized enterprises will be fundamental to the next chapter of DeepIntent’s growth,” said DeepIntent’s Founder and CEO. Chris Paquette said. “Amit is uniquely qualified to strengthen our core business operations while evolving them into a world-class, high-performance team capable of unlocking even greater value for our customers.”

Earlier this year, DeepIntent announced a range of new hires and promotions to solidify its position as the leading omnichannel platform for healthcare marketingincluding high-growth channels such as CTV, where the platform’s ad spend grew more than 25x in 2021.

“The pharmaceutical industry is at a crossroads. Healthcare marketers have long recognized the value of advertising, but most brands have historically prioritized linear television. This dynamic is changing as the media consumption is changing. With the right people, unique technology and a clear vision for the future, DeepIntent will continue to lead the shift to programmatic in the pharmaceutical industry,” said Chaturvedi.

Chaturvedi graduated from New York University with business management certificates from Harvard Business Schoolthe MIT Sloan School of Managementand the Haas School of Business in University of California, Berkeley.

To learn more about working for DeepIntent, visit

About DeepIntent

DeepIntent leads the healthcare advertising industry with data-driven solutions built for the future. Purpose-built for healthcare marketers, DeepIntent’s platform is proven to improve audience quality and script performance. It allows marketers to plan, activate, measure and optimize their campaigns within a single platform. Designed by former Memorial Sloan Kettering data scientists, DeepIntent enables nine of the top ten pharmaceutical companies and leading healthcare advertising agencies to improve patient outcomes through the artful use of advertising, data science and real health data. For more information, visit or find us at TwitterFacebook or LinkedIn.

Press contacts:
Finn Partners for DeepIntent
Chris Shattuck
[email protected]
678 504 6785



See original content to download multimedia:

SOURCE DeepIntent


Comments are closed.